INBS
Intelligent Bio Solutions Inc.
Mentions (24Hr)
0.00% Today
Reddit Posts
It’s Humpday! 🐫 4 picks for today are: $BCNN consolidating at .0035. Beat down bouncers includes $INBS getting tighter , $GBUX accumulation heading up and $AIRE wants to head back over $100 !
The morning 4 has to kick off with $AIRE that went from $4-$17 in AH trading this was $500 in mid Nov. $INBS is currently consolidating for its next step up. $BCNN needs to hold .0035 support for the next bounce. $ZHUD closed up 15% as we keep waiting for the breakout.
$BSFC in early just like. RNAZ,ICU, and INBS
$INBS UP .16 AH On Missed Earnings
$INBS After hours runner! Did anyone join when I alerted
$INBS low float company with 1.87 million share float that just had contact news recently
Terrible companies to watch for multi baggers next week
Stop chasing runners. Watch these next week.
Mentions
Fair point generally, but INBS isn’t pre-revenue, they’re already selling internationally and just reported record quarterly revenue. This partnership is about cutting costs and scaling production ahead of U.S. entry, not a “hope it works someday” biotech. Still risky, just a different kind of risk.
INBS not going to $10 today. You made a profit; you done good.
Thank you for the guys who said INBS
INBS halted after 1 minute.
INBS pushing on now and could well continue throughout the day.
Watching INBS after open. Small float, good news with (some) numbers.
Couldn’t agree more. I’ve seen people dumping solid setups just because of one red day. Meanwhile, $NXXT yeah, it’s a microcap penny stock, but it’s been consolidating really well for weeks. Same story with a few others I’ve been watching like $MYNZ, $INBS, $AIMD, and $BNZI. These tiny caps test your patience, but when they move, they really move
INBS looks like FDA is upcoming soon. It ran a bit on Friday with large order investors coming in. Fingerprint drug testing in use in UK, Africa and Middle East. FDA will open up USA use.
A few medical tangent plays. All awaiting FDA soon. But not meds. MBOT robot cardiovascular MDAI AI modeling for burn treatment INBS fingerprint drug testing Also a TOTAL wildcard out there idea. GPRO They began offering user videos to be sold for AI training and modeling. Users get paid and they get a cut. It’s a new revenue stream that could be a turn around for them… maybe.
See my post above.....WV isn't telling full story. Look at stock earnings. Very mixed. INBS is a long term play.
Why do people leave out important details about a stock. Like INBS cash reserve has decreased by about two thirds and their net loss has widened. Dude, tell the full story about a stock. INBS is a long term play. FDA catalyst could take a while. Alot of things need to happen with this stock.
I am watching since last week and I am thinking of opening a position. I have not enough knowledge about all this pharma procedures. So far I understand that FDA will reply in the next couple of weeks. But will they only reply, if they accept the new submitted data from INBS and name a new period for a final approval (what I am suggesting right now)...or will the reply from FDA already be the decision of the approval? I don't know why you got a downvote for your comment :-)
INBS Record sales reported this week and FDA catalyst coming soon. Looking to revolutionize noninvasive drug testing. Could be a big thing with hiring and roadstops imo. Bouncing back and forth between 1.46-1.53
Cannot leave out INBS. They have good news after good news lately and just submitted additional information for fda approval. They will have an answer by September
INBS MBOT both are technically medical but fringe and expecting FDA approvals soon(ish)
I mean I’m not saying it’s a crazy stock that’s gonna blow up but amazon was way in the red for 7 years straight. All I mean is that they have some new technology that’s come out the last little while that other countries are adapting to pretty well and the U.S. holds a huge piece of the market. Also INBS set their price wayyyy to high from the get go. Only 5 years old tho so not a bad time to start moving back up into the green
One that’s been pretty good to me is intelligent bio solutions (INBS) non invasive drug testing company. They are currently waiting for FDA approval but it’s looking great to me so far. It pretty consistently shoots from $1.60ish up to $2.20ish but once they have they get fda approved I can see them having a good jump
Thanks for the advice and the stock tip. I am going to choose to stay away from INBS for now just because of the market capitalization potential. I do not see as large of a market compared with MBOT and surgical devices. I do not doubt the device will be great and all but I just don't see it being as big of a gainer or company as MBOT has the potential to be.
Anytime. With my company I have the right to purchase shares yearly at a discounted rate (some companies do quarterly). The company in turn gives me 1/3 of those shares yearly over 3 years. Rinse and repeat. I'm not C-level, however this is meant to retain good employees. **Example**: (Simulated $50/share stock) 2025 - I buy 100 shares @ $45 (SP = $50 x 10% = $45/share) Cost basis: $4500 2025 - Company gives me 33.3 shares 2026 - Company gives me 33.3 shares 2027 - Company gives me 33.3 shares 2028 - I cash out and leave and SP is now $100/share. ($10,000 - CB $4500 = realized profit of $**5,500** (minus taxes of course) I highly recommend you look at $INBS. Already have an FDA 510K filed and extremely positive results. *Not financial advice, do your own diligence, and all that. Happy investing!!*
Dude, is this post just to pump IXHL? I suggest some of you take a look at INBS. Already in use in Europe, Middle East, and Australia, waiting on FDA approval in the U.S. Sitting at $2.08 today, once FDA approval comes for their fingerprint/sweat drug testing we may see a buyout or a nice jump in price. This isn’t a quick flip, you are waiting for approval, we might not see any news until September-December. DCA and wait. Price went from $2.26 to $1.50 after the FDA asked for more info. PT $7+. They also just came out with a 10 day drug detection patch, so they are continuing to build on their tech.
they were asked to submit addition info to the FDA. That pauses the 90day turn around period. INBS has 180 days to respond once asked to provide additional info. Most companies will wait and take the entire time to make sure they give everything needed. That was back in march, meaning deadline is around end of September. They may not even announce they have responded to FDA. They could have already and waiting to hear back.
Both INBS and INVZ with catalysts today. Let’s gooooo!!
I think TRBRF is an unknown but solid contender. It’s just a healthy vegan protein bar called Trubar. It tastes good, none of the bullshit ingredients that most other protein bars have. It’s growing extremely fast on Amazon, expanding into Costco’s all over, and just feels like a solid buyout contender for a bigger brand. Very high risk high reward play is INBS. Their financial statements are not good currently, but are awaiting FDA approval for their fingerprint drug test that works on sweat, rather than blood, urine, or hair. The play is completely dependent on the FDA approval and successful expansion into the US market. They’re at like a $10mm market cap, so the moonshot potential from a single contract or new client in the US is there. However, they could proceed like most shitcos and continuously dilute, RS, until they’re delisted and you’ve lost all your money.
INBS is a company that patented a fingerprint drug test that uses sweat from your finger, takes 10 minutes for results, and is 94% accurate. Already approved in Europe, Middle East, and Australia. Waiting on FDA approval, FDA asked for more info in March, should see approval by EOY. Just recently partnered with Smartox to help scale NA distribution. They are a buyout candidate, but have already approved dilution to help scale up, just fair warning. I think it’s at $1.85 a share. Check it out, let me know what you think. GL!!!
INBS is almost a certain to get FDA approval this summer. Everything is falling into place
Let INBS give him a drug test then I'll believe it
I have tried to tell you. The correct ticker is INBS Low float working product medical companies. FDA approval imminent which will let it fly to new highs. Thank me later
INBS a rough couple of weeks are behind us. They have a working product, they are CE certified in EU and it’s missing the FDA approval. Once this is here I’m certain this could go mental. Anyways good luck to you all!
I have practically no idea what I'm doing but, I have my bets on KULR, PDSB, INBS and SOFI (yeah, I know, not technically a "penny stock" anymore but I could see them 10x in the next 5-/+ years or less. Just my opinion, which I've already stated is basically worthless
NWTG had insiders buying, coming off of great earnings, insiders buying and nice upside premarket INBS, good earnings, just launched good data of their device -actually working-. Not saying that they're going to "pump" today, however, something to consider/research for the long term investors (if there are any here lol)
Yeah I’m in INBS is my main holding. Hopefully they can last the summer and don’t need to do a share offering until FDA approval comes through.
INBS had bullish news yesterday (just made a post about this in the main thread). It also hit my scanners with 1. Nasdaq ticker 2. Price under $2 3. Positive news in the last 24 h 4. Relative volume over 3x 5. Float under 10 M (this was like 6-7M) 6. % change over 10% 7. If the volume pickes up, we might see some movement, as the float is that low.. but who knows, in these market conditions is hard to say...
What are some stocks that haven’t caught up to this wild pumping? I’m looking at INBS / CAVA / RDDT
Check out INBS only 8M market cap. Some of the guys here could buyout the entire company 😂
INBS FDA approval is imminent
Hoping INBS has news about FDA this week if not it will be another 90 days.
INBS has potential if they get FDA approval in the USA for the fingerprint drug testing. Already in use in UK, EU and Africa. I hold a stake but not trying to sell currently up 28% for me.
The FDA approval could be a week away or a month away, we don't know. They aren't required to complete the approval process in 3 months, that's just an average about of time. Trump also fired/re-hired a ton of FDA workers right in the middle of INBS approval process so who knows when we will here something. That said, I think this one is a winner. It may not spike as high as we want after approval, but the long term potential of this product, provided they can get it off the ground in US, is very very promising.
The market is huge --but INBS needs to prove they can execute on increasing revenues to the point of being cash flow positive.
INBS could make you some good money in the coming months.
Hmm.. interesting OP. Some somewhat relevant shit I found: 148% year-over-year revenue growth in fiscal 2024 Gross profit margin increased to 38.5% from 27.7% Expanded customer base to 400 accounts across 19 countries 94% accuracy demonstrated in Method Comparison Study Completed FDA 510(k) submission for U.S. market entry “The pending FDA 510(k) submission represents a important catalyst. The strong clinical data, showing 94% accuracy in Method Comparison Studies and favorable Pharmacokinetic study results, strengthens the likelihood of regulatory approval. The U.S. market entry timing aligns well with concerning trends in workplace drug use, including a six-fold increase in test tampering and rising positivity rates for marijuana (4.7% YoY) and cocaine (9.1%).“ This info is from [this link](https://www.stocktitan.net/news/INBS/intelligent-bio-solutions-releases-shareholder-letter-detailing-2024-t7qdv1oot050.html). Just what I found with some light googling. That said, am considering opening a small position on the gamble.
$INBS is the only play my fellow degenerate brethren -imminent FDA decision -nice cup and handle on the 6M chart
I like the potential of $INBS, has anyone done a DD, I am up 20%. I am planning a long term hold.
INBS is the only correct answer
INBS fda approval should be this month. Already approved in multiple Euro countries. This $14 mil market cap stock will be 10x by April IMO and has 100x potential in a year or two.
INBS INBS INBS. I was the 1 post. Lets do it again INBS INBS INBS
Short term of 1-2 month time horizon would be ARVN (April 17th $20 calls), INBS (shares - no options available), SWTX (shares - options to inflated) …. Medium term of 3-6 month time horizon would be APLD (June 20th $10 call)….. Long term (never selling)…. LPTH, TARS and maybe ROOT & IONS. Not financial advice and all that.
What are you talking about. INBS never hit .6 I think the lowest was .99
Investing is like gambling... Doesn't mean you need to go all in with every hand... STI applied for a patent for a battery which will be a huuuge improvement on lithium ones At .38 last I checked$ INBS is a non intrusive drug test, already licensed in EU, applying for licensing in US, if it's approved then it will probably 5x Currently at 2$
I did not know that. Thank you. INBS!!
Like this " INBS " script wont count if it is not all capital letters
It's gonna be a good while before INBS goes up. But stay in it for the long haul and maybe it'll be worth it
I think INBS is interesting but HMR is setting up to double! $HMR!
Whoever called INBS, thank you!!
Yeah been holding INBS and I’m hopeful. In at 1.50ish…
I've been in INBS since November. It was on an absolute tear before the slump - this is the real deal, their product is legit, I consider them a long term play
I do options occasionally but yes it’s a lot like gambling and I’ve had some nasty losing streaks. I try to only use options on very high probability trades and get out with profit as soon as possible. Tsla losing sales is just a logical necessity as Musk has become far right seemingly out of nowhere. His customer base is definitely left leaning and he has absolutely spit in their faces and doing so every day. INBS has a drug testing device that has gotten popular quickly and will likely catch on in the US fast. It’s not a complicated idea though the technology is a bit over my head how it actually works. I think from a 12 mil market cap a 100 bagger is a definite possibility over the next 3-5 years.
Do you mostly do options and short term trades? I don't really trade... All of my gains have been concentrated long positions where I feel like I have unique knowledge that I expect to 10x or more in 5-10 years. Boring, I know. But my positions are now big enough that I see $50-100k movement daily and $250-500k swings on big movement days, which is more than enough excitement for me. The few times I tried options, I've made a little and lost a lot... Probably lost $100k in options gambling in 2022 alone. I'm finally going to offset all of those loses from my 2024 diversification sales out of TSLA at \~$410. As for Tesla, you need to be careful with reading headlines... I've seen first-hand how most "news"/"articles"/etc are actually so out-of-context that they are completely useless or suggest the complete opposite of what's actually happening. The big eye-opener was back in 2015 when I saw a video clip from CNBC summarizing a shareholder meeting where they spliced together a question and response that were not related to make Tesla look bad. I was shocked. Used to laugh at all the "fake news" people, but wow. I couldn't believe how blatant it was. That's how I developed my strong conviction in Tesla back then -- I kept seeing horrible news about the company and vehicles, but I owned the car and interacted with the company and both were fantastic beyond my highest expectations. I now ignore all media from all sides and just look at cold hard facts and numbers directly from the source. In this case, delivery and demand may be softening, but a new Model Y is just becoming available and all potential buyers have known this for at least a year (since the refreshed Model 3), so we wouldn't know if demand is really "collapsing" until end of Q2. And if Q2 looks good, we need to wait until end of Q3 or Q4 to really know if the Q2 numbers were just a temporary surge of pent-up demand. And then Tesla has announced an intention to launch a new model this year, so I view any short term bets would be extremely risky. All of that is still just short-to-medium term to me. The long-term trends will trump the short term noise. And the only long-term trend that really matters in the coming decade is AI. There's going to be a LOT of money to be made in the AI revolution which will make the Internet revolution look like peanuts. If we play it right, we can all get rich(er) in the coming years. INSB or INBS? INBS is in the biotech sector? I don't know enough about biotech to feel I have an edge. But biotech will 100% benefit from AI augmented research in the coming years. I hope that will yield a lot of benefits to humanity in addition to generating a lot of wealth for investors. Do you have a deep read on the pulse in this segment? Or in the company specifically?
Just SOBR and INBS 🔥
https://www.stocktitan.net/news/INBS/intelligent-bio-solutions-inc-announces-pricing-of-2-6-million-8qtm0toukz2w.html
outside of pennies for a moment, Still a good day, got HIMS at 60, sold at 72, INBS moving nicely, Poet moving well, LUNR gonna have a rocket launch with SpaceX to go to the MOON literally Feb 26. Profit is profit, remember other things still exist. Lots of people playing RXRX and doing well.
Long INBS. FDA approval coming next month. Already approved in Europe. Easy $
I am looking for opinions on INBS. I like the stock and think the product has great potential. The issue I am hung up on is the fact that they are spending so much money on sales ( 9.26 million) in 2024 which only turned into 3.11 million in revenue. INBS is using stock issuance to fund sales and keep the company alive. We would need to see a revenue increase of 300% just to overcome the sales costs. Breaking into the U.S. market could increase market cap but I don't see how sales spending could go down. They still have to market and sale to get a foothold in the U.S to increase revenue. Playing the devils advocate here but I don't foresee revenue compensating for sales costs anytime soon. I foresee cont8nued stock issuance which will continue to dilute the price. I want to believe in it but unless Sales costs go down I don't see the value quite yet.
INBS about to make big moves. FDA approval in a few weeks 🤑
INBS looking good at least
INBS has momentum today too, not sure how many of you holding this one.
waiting to sell this so i can buy INBS lol
That was me actually! Cheers to INBS's recent momentum.
INBS is looking solid lately… entering USA market soon.
Penny stocks are notably tough to decipher what is a PnD, short play, or a long-term breakout candidate. As with all other stocks you have to diversify your penny portfolio so one bad news day doesn’t completely decimate your portfolio. Breakout candidates: GRRR, INBS, MBOT, KULR Recent buys: LFWD, LUCD, CPSH, TLS
Please do your research before comparing this product to Theranos. INBS is already in European markets and expanding. FDA approval is not a matter of if but a matter of when! It’s a low float stock even if it doesn’t get bought out it will fly after the FDA catalyst. It’s already moving today and the earnings call is not even out (expected this week)
I’ve been in INBS for a while, found it a few months ago and already have double digit percent gains. Saw the comments on your other posts - I get why people are hesitant to buy after it’s recent run, but Jesus if this goes somewhere they’re gonna shit their pants for how much they clowned on you for “theranos 2.0.” I don’t think they even looked up the company or its cartridge tests at all.
I thought you were going to say you just bought INBS ($2.10) lol. It has a 4m float, plus 9% short interest. The company has a revolutionary rapid drug testing device that only uses a fingerprint to drug test, so instead of sending blood and urine samples to a lab to be tested, they simply just use your fingerprint to get an instant result. FDA approval is due March 18th, which is a huge catalyst. Either way, with the float being only 4m, with the high short interest, it's probably a 10x bagger at any time with FDA approval looming. Thought for sure you were going to mention this stock though, lol.
This is the type of news i like. I figured if they were to be bought out it would be by either quest or labcorp since neither one has a treat remotely close to INBS's. Definitely gonna keep holding. Might buy a few more shares too.
Hey man appreciate the insight, so I’ll give a little bit of my own. Can’t really say more about this stock but one I think you might like looking into INBS, financials are a little shot, but the idea is crisp and applicable.
I have been holding INBS for about 6 months. They have been in the red for most of it. I do expect to see some great expansion….though I think $40 is stretching it a bit. Musk just recently came out saying he wants drug testing for all government employees. I wonder if that includes him…LOL INBS has a unique and solid plan. Already in use in UK, EU and the Middle East. The cartridge repurchases will drive profits. Here is hoping.
Here is the Big One. INBS ($2.10) has a revolutionary rapid drug testing device that does instant drug testing by using only a fingerprint. So instead of sending blood or urine samples to a lab to be tested and waiting a couple of days for the results, they can now just simply use your fingerprint and get an instant result right there on the spot. It's pending FDA approval for use in the U.S., which is due next month by March 18th, at which point I hope it goes to $40 a share! lol. I'm sure the company will be acquired right after FDA approval next month, which will be my second buyout so far this year.
Here are a few that aren’t mentioned here as often that I’m following or already hold. INBS GTI BGI SLDP SKYX SDST if anyone is looking for out of the box thinking. Longer term hold stuff. Potential good long term profits.
Here is one headed for greatness. INBS ($2.10) has a revolutionary new drug testing device that does rapid drug testing by using only a fingerprint. So instead of sending blood or urine samples to a lab to be tested and to wait a couple of days for the results, they can now just simply use your fingerprint and get an instant result right there on the spot. It's pending FDA approval for use in the U.S., which is due next month by March 18th, at which point I hope it goes to $40 a share lol
Here is one you guys might like. INBS ($2.10) has a revolutionary new drug testing device that does rapid drug testing by using only a fingerprint. So instead of sending blood or urine samples to a lab to be tested and to wait a couple of days for the results, they can now just simply use your fingerprint and get an instant result right there on the spot. It's pending FDA approval for use in the U.S., which is due next month by March 18th, at which point I hope it goes to $100 a share, lol.
I have shares in RANI, NIVF, and INBS. Its nice to see NIVF going up 10% AH. Not sure what RANI is doing and I might end up selling. What does everyone think about these three?
INBS have already been approved for use by the European Medicines Agency (EMA), which is why the device is already being successfully sold in Europe. Also, the EMA is considered to have even stricter guidelines for approval of medical devices than the FDA, and the odds of an EMA approved device getting FDA approval is approximately 95%. People comparing this device to Theranos haven't done any research. The device screens for drugs using fingerprint sweat, not DNA analysis. Companies all over the world are using this device every day. Their gross profit margin increased to 38.5% from 27.7% , according to their recent financial reports.
INBS have already been approved for use by the European Medicines Agency (EMA), which is why the device is already being succesfully sold in Europe. Also, the EMA is considered to have even stricter guidelines for approval of medical devices than the FDA, and the odds of an EMA approved device getting FDA approval is approximately 95%. As for privacy concerns, INBS’s device screens for drugs via fingerprint sweat analysis, not DNA analysis. The technology is focused on detecting metabolites from substances, not genetic material.
INBS have already been approved for use by the European Medicines Agency (EMA), which is why the device is already being succesfully sold in Europe. Also, the EMA is considered to have even stricter guidelines for approval of medical devices than the FDA, and the odds of an EMA approved device getting FDA approval is approximately 95%. If the device didn't already have over 400 companies successfully relying on it for screening across the globe, that would be one thing.